Specific germline mutations in the rearranged during transfection proto-oncogene (RET) have a pathogenic role in the onset of familial MTC (FMTC) or MEN2, the two clinical forms of hereditary MTC [2–4]. Here, RET is linked to medullary thyroid gland carcinoma.